Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
Eli Lilly Will File For Retatrutide Approval—As Study Shows Average Weight Loss Of 56 Pounds
Posted
July 23, 2026
Views
1,929
Likes
6
Comments
1
Engagement
July 23, 2026
1,929
6
1
0.36%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:16Now PlayingEli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
